(Q42263840)

9 January 2018

title

Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population (English)

1 reference

9 January 2018

1 reference

hepatocellular carcinoma

1 reference

1 reference

1 reference

Anne C Moorman

6

0 references

author name string

Stuart C Gordon

1

1 reference

9 January 2018

Lois E Lamerato

2

1 reference

9 January 2018

Loralee B Rupp

3

1 reference

9 January 2018

Jia Li

4

1 reference

9 January 2018

Scott D Holmberg

5

1 reference

9 January 2018

Philip R Spradling

7

1 reference

9 January 2018

Eyasu H Teshale

8

1 reference

9 January 2018

Vinutha Vijayadeva

9

1 reference

9 January 2018

Joseph A Boscarino

10

1 reference

9 January 2018

Emily M Henkle

11

1 reference

9 January 2018

Nancy Oja-Tebbe

12

1 reference

9 January 2018

Mei Lu

13

1 reference

9 January 2018

CHeCS Investigators

14

1 reference

9 January 2018

language of work or name

English

0 references

publication date

6 October 2013

1 reference

9 January 2018

Clinical Gastroenterology and Hepatology

published in

1 reference

9 January 2018

volume

12

1 reference

9 January 2018

issue

5

1 reference

9 January 2018

page(s)

885-893

1 reference

9 January 2018

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Lamivudine for patients with chronic hepatitis B and advanced liver disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Histological outcome during long-term lamivudine therapy.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

The performance of different propensity-score methods for estimating relative risks

1 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine

1 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5719871

10.1016/J.CGH.2013.09.062

1 December 2018

Identifiers

DOI

1 reference

9 January 2018

PMCID

5719871

1 reference

9 January 2018

PubMed ID

24107395

1 reference

9 January 2018